Pfizer rises after quarterly profit beat, maintains 2025 forecast
Pfizer's PFE.N shares rise 1.7% to $23.44 premarket
PFE posts Q1 adj EPS of $0.92, beating analysts' estimates of $0.67, per data compiled by LSEG
While Q1 revenue misses estimates, but still sticks by FY revenue forecast of $61-$64 billion
Also maintains FY adj EPS outlook of $2.80-$3.00
As of last close, PFE has fallen about 13% YTD
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
Micron Stock Forecast: Can the AI Memory Super-Cycle Drive MU to $3,000 by 2030?

Tesla Opens Up Over 2%, Shares Return to $400, Here Is What Investors Need to Note

Gold Price Forecast: U.S.-Iran Tensions Ease, Nonfarm Payrolls Looming, What’s Next for Gold?

SpaceX IPO Approaches: Musk Dissolves xAI into SpaceX and Subleases 300MW Compute to Anthropic; Can the $2 Trillion Valuation Hold?

WTI and Brent Futures Both Fall Below $100 Mark, Have Oil Prices and Energy Sector Peaked?

Tradingkey








